113 related articles for article (PubMed ID: 1937329)
21. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
[TBL] [Abstract][Full Text] [Related]
22. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
[TBL] [Abstract][Full Text] [Related]
23. [Therapy of hyperlipoproteinemia].
Drexel H; Follath F
Schweiz Rundsch Med Prax; 1993 Apr; 82(17):506-9. PubMed ID: 8493437
[TBL] [Abstract][Full Text] [Related]
24. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
25. Plafibride treatment and serum lipids in hyperlipoproteinemias.
Rodriguez F; López IM; Jover E
J Med; 1987; 18(3-4):153-63. PubMed ID: 3323393
[TBL] [Abstract][Full Text] [Related]
26. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Vessby B; Lithell H; Gustafsson IB; Borberg J
Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
[TBL] [Abstract][Full Text] [Related]
27. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
Pristautz H; Stradner F
Wien Med Wochenschr; 1986 Sep; 136(17):443-8. PubMed ID: 2879389
[TBL] [Abstract][Full Text] [Related]
28. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
[TBL] [Abstract][Full Text] [Related]
29. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
[TBL] [Abstract][Full Text] [Related]
30. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
[TBL] [Abstract][Full Text] [Related]
31. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. II. Results of the treatment in relation to the type of hyperlipoproteinemia].
Sznajd J; Idzior-Waluś B; Korzus G; Zabiński J; Hebda A; Markiewicz M
Przegl Lek; 1990; 47(10):711-4. PubMed ID: 2089450
[TBL] [Abstract][Full Text] [Related]
32. Serum lipoprotein fatty acid patterns in various types of familiar combined hyperlipidemia.
Hrebícek J; Chmela Z; Skottová N; Bartek J; Vecera R
Acta Univ Palacki Olomuc Fac Med; 1995; 139():19-23. PubMed ID: 8686553
[TBL] [Abstract][Full Text] [Related]
33. [Effect of low dose omega-3 fatty acid supplementation on plasma lipids and lipoproteins in coronary patients with dyslipoproteinemia].
Schindler OS; Rost R
Z Ernahrungswiss; 1996 Jun; 35(2):191-8. PubMed ID: 8766893
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of plasma and biliary lipids in hyperlipoproteinaemia.
Leijd B
Acta Med Scand Suppl; 1979; 635():1-32. PubMed ID: 295570
[No Abstract] [Full Text] [Related]
35. Studies on the phenotyping system of hyperlipoproteinemias. Evaluation of a new method by enzymic staining of lipids in serum lipoproteins separated by electrophoresis on agarose.
Ohno F; Suehiro T; Uga S; Kawada M; Takamatsu K; Yasuoka N; Yamano T
Jpn J Med; 1983 Aug; 22(3):200-5. PubMed ID: 6620708
[TBL] [Abstract][Full Text] [Related]
36. [Fatty acid metabolism in primary hyperlipoproteinemia (HLP) (author's transl)].
Reuter W
Dtsch Z Verdau Stoffwechselkr; 1979; 39(3):124-9. PubMed ID: 520271
[TBL] [Abstract][Full Text] [Related]
37. Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia.
Bradford RH; Goldberg AC; Schonfeld G; Knopp RH
Atherosclerosis; 1992 Jan; 92(1):31-40. PubMed ID: 1575820
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of various types of hyperlipoproteinaemia with a combination of Mg-chlorophenoxy-isobutyrate and mesoinositol-hexanicotinate (author's transl)].
Bolzano K; Krempler F; Haslauer F
Arzneimittelforschung; 1979; 29(10):1621-4. PubMed ID: 583231
[TBL] [Abstract][Full Text] [Related]
39. Variations in lipids and proteins of lipoproteins by fenofibrate in some hyperlipoproteinaemic states.
Avogaro P; Bittolo Bon G; Belussi F; Pontoglio E; Cazzolato G
Atherosclerosis; 1983 Apr; 47(1):95-100. PubMed ID: 6870993
[TBL] [Abstract][Full Text] [Related]
40. Pre- and post-treatment values of HDL cholesterol and total: HDL cholesterol ratio in hyperlipoproteinaemic subjects.
Sale JK; Johnstone JH
Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():71-5. PubMed ID: 7259072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]